| Financial Year |
March 31 2023 |
| Monetary Funds |
1,533,039,370.00 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,049,210,670.74 |
| Advances to Suppliers |
5,575,737.10 |
| Other Receivables |
1,146,323.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,415,067.80 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
103,556,190.87 |
| Other Current Assets |
52,711,355.79 |
| Total Current Assets |
2,860,788,595.95 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
770,061,005.71 |
| Long-term Equity Investment |
29,891,639.61 |
| Investment Properties |
43,358,068.86 |
| Fixed Assetes |
29,698,277.69 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
10,654,999.90 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
237,364.67 |
| Deferred Income Tax Assets |
57,171,311.96 |
| Other Non-Current Assets |
922,275,221.34 |
| Sub-Total of Non-Current Assets |
1,945,703,046.18 |
| Total Assets |
4,806,491,642.13 |
| Short-Term Loans |
42,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
42,785,399.15 |
| Accounts Payable |
264,928,868.94 |
| Accounts Received In Advance |
150,000.00 |
| Employee Compensation Payable |
10,413,673.78 |
| Taxes Payable |
27,541,193.85 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
19,765,462.64 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
114,031,622.17 |
| Other Current Liabilities |
80,573,521.08 |
| Sub-Total of Current Liabilities |
758,897,261.06 |
| Long-term Loans |
935,887,696.65 |
| Bonds Payable |
616,714,516.85 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
46,324,615.53 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,598,926,829.03 |
| Total Liabilities |
2,357,824,090.09 |
| Paid-In Capital(Or Share Stock) |
312,000,000.00 |
| Capital Surplus |
836,014,498.91 |
| Surplus Reserve |
116,623,105.37 |
| LESS:Treasury Stock |
79,745,391.23 |
| Undistributed Profits |
1,080,785,005.76 |
| Minority Stockholder's Interest |
61,669,137.04 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,386,998,415.00 |
| Owner's Equity（Stockholder's Equity） |
2,448,667,552.04 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,806,491,642.13 |
